SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance

BACKGROUND: Methyltransferase SETDB1 is highly expressed in breast cancer (BC), however, the mechanisms by which SETDB1 promotes BC progression to endocrine therapy resistance remains elusive. In this study, we examined the mechanisms by which SETDB1 contribute to BC endocrine therapy resistance. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zexuan, Liu, Junhao, Ebrahimi, Behnam, Pratap, Uday P., He, Yi, Altwegg, Kristin A., Tang, Weiwei, Li, Xiaonan, Lai, Zhao, Chen, Yidong, Shen, Liangfang, Sareddy, Gangadhara R., Viswanadhapalli, Suryavathi, Tekmal, Rajeshwar R., Rao, Manjeet K., Vadlamudi, Ratna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991965/
https://www.ncbi.nlm.nih.gov/pubmed/35395812
http://dx.doi.org/10.1186/s13058-022-01520-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991965/
https://www.ncbi.nlm.nih.gov/pubmed/35395812
http://dx.doi.org/10.1186/s13058-022-01520-4

Ejemplares similares